Deprecated: abs(): Passing null to parameter #1 ($num) of type int|float is deprecated in /home/individends/public_html/financial_analysis.php on line 303

Profitability Metrics

Gross Margin
83.51%
Operating Margin
79.75%
Net Margin
43.74%

Efficiency Metrics

Revenue per Expense Ratio
4.94
R&D as % of Revenue
0.00%

Earnings Quality

EBITDA Margin
0.00%
Income Tax Rate
0.00%
EPS
0.3600000000

Balance Sheet Analysis

Current Ratio
1.66
Cash Ratio
0.00
Working Capital
$295.29K
Debt to Equity
0.70
Debt to Assets
41.09%
Equity Ratio
58.63%

Cash Flow Analysis

Operating Cash Flow Ratio
10.13%
Free Cash Flow Ratio
10.13%
CapEx to Revenue
0.00%
Dividends Paid
$842.56K
Stock Buybacks
No buybacks
Total Shareholder Returns
$842.56K
Cash Position Change
-80,000,000.0%

Key Takeaways (2023 FY)

  • Maintained positive net income growth despite revenue changes
  • Increased R&D investment by 100.00%

Detailed Growth Metrics

Core Performance

Revenue
280.44%
Net Income
171.10%
EPS
170.59%
Operating Income
5.96%

Operational Efficiency

R&D Expenses
100.00%
SG&A Expenses
231.90%
Operating Cash Flow
180.58%
Free Cash Flow
180.58%

Balance Sheet Health

Assets
-0.31%
Debt
56,195.58%
Book Value per Share
-0.08%
Inventory
0.00%

Shareholder Returns

Dividends per Share
-7.56%
Shares Outstanding
0.00%

Long Term Trends

3Y Revenue/Share
-22.77%
5Y Revenue/Share
-9.86%
3Y Dividend/Share
-27.39%
5Y Dividend/Share
-30.85%